The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
NCT ID: NCT01825161
Last Updated: 2022-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
454 participants
OBSERVATIONAL
2013-08-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00002461
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
NCT05251805
Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
NCT01006070
Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
NCT02278744
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
NCT02441309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 75 years
* Able to read and write English at an elementary level
* Diagnosis of metastatic tumor of the spine
Exclusion Criteria
* History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening
* Is a prisoner
* A disease or condition that would, in opinion of the investigator, preclude accurate evaluation (e.g. significant psychiatric disease)
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orthopaedic Research Foundation
OTHER
AO Foundation, AO Spine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles G Fisher, MD
Role: PRINCIPAL_INVESTIGATOR
Vancouver General Hospital and the University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kansas University Medical Center
Kansas City, Kansas, United States
Johns Hopkins University
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center
Houston, Texas, United States
Vancouver General Hospital
Vancouver, British Columbia, Canada
Sunnybrook Health Sciences Center
Toronto, Ontario, Canada
University of Toronto Hospital
Toronto, Ontario, Canada
Montreal General Hospital
Montreal, Quebec, Canada
National Center for Spinal Disorders
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barzilai O, Sahgal A, Rhines LD, Versteeg AL, Sciubba DM, Lazary A, Weber MH, Schuster JM, Boriani S, Bettegowda C, Arnold PM, Clarke MJ, Laufer I, Fehlings MG, Gokaslan ZL, Fisher CG; AO Spine Knowledge Forum Tumor. Patient-Reported and Clinical Outcomes of Surgically Treated Patients With Symptomatic Spinal Metastases: Results From Epidemiology, Process, and Outcomes of Spine Oncology (EPOSO), a Prospective, Multi-Institutional and International Study. Neurosurgery. 2024 Nov 1;95(5):1148-1157. doi: 10.1227/neu.0000000000002989. Epub 2024 Jun 4.
Related Links
Access external resources that provide additional context or updates about the study.
AOSpine
Orthopedic Research Foundation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPN-12-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.